Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Cents and Sensibility - Kimberly and Friends' Consortium -- Ignore unavailable to you. Want to Upgrade?

To: DO$Kapital who wrote (30990)	11/21/1999 1:54:00 AM
From: Kevin McKenzie	Respond to of 108040

Here's something I really can't comprehend about the markets: Comdex (CMDX) and Fisher Scientific (FSH) are direct competitors in the the sale of life sciences products to various enterprises. FSH has TTM revenues of $2.4 Billion, and a price-to-sales of .47 (that's point 47). CMDX has TTM revenues of $11.6 million, and a price-to-sales of 45. CMDX has a float of 7.5 million and a market cap of $2.18 Billion. FSH has a float of 12.8 million and a market cap of $1.08 Billion (half of CMDX's) FSH has a huge pipeline of customers, including a recently consummated a 5 year e-commerce contract with Chiron, which is estimated to be worth $250 million (that's just for this one contract). I know that Fisher Scientific is now, and will continue to be the dominant reseller of supplies to the life sciences community. Chemdex will probably never approach Fisher's revenues. If they do, it will take years, yet CMDX is already worth twice as much as FSH. I know it's just a game, but it's so hard to make sense of the rules.